Cargando…
Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-Gingerol in cervical cancer cells
Human papilloma virus (HPV) expressing E6 and E7 oncoproteins, is known to inactivate the tumor suppressor p53 through proteasomal degradation in cervical cancers. Therefore, use of small molecules for inhibition of proteasome function and induction of p53 reactivation is a promising strategy for in...
Autores principales: | Rastogi, Namrata, Duggal, Shivali, Singh, Shailendra Kumar, Porwal, Konica, Srivastava, Vikas Kumar, Maurya, Rakesh, Bhatt, Madan L.B., Mishra, Durga Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791234/ https://www.ncbi.nlm.nih.gov/pubmed/26621832 |
Ejemplares similares
-
Therapeutic targeting of cancer cell cycle using proteasome inhibitors
por: Rastogi, Namrata, et al.
Publicado: (2012) -
Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway
por: Gara, Rishi Kumar, et al.
Publicado: (2015) -
Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation
por: Yeo, Shi Yun, et al.
Publicado: (2016) -
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms
por: Allen, Mary Ann, et al.
Publicado: (2014) -
SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
por: Carvalho, Sílvia, et al.
Publicado: (2014)